US Bancorp’s Capricor Therapeutics CAPR Stock Holding History

US Bancorp’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Sell	14,235 -198	-1%	-$6K	﹤0.01%	1820
2026 Q1	$439K	Buy	14,433 +1,803	+14%	+$48K	﹤0.01%	1569
2025 Q4	$365K	Buy	12,630 +5,168	+69%	+$67.5K	﹤0.01%	1705
2025 Q3	$53.8K	Hold	7,462	–	–	﹤0.01%	2644
2025 Q2	$74.1K	Sell	7,462 -106	-1%	-$1.12K	﹤0.01%	2589
2025 Q1	$71.8K	Buy	7,568 +53	+0.7%	+$736	﹤0.01%	2553
2024 Q4	$104K	Buy	7,515 +53	+0.7%	+$929	﹤0.01%	2380
2024 Q3	$113K	Hold	7,462	–	–	﹤0.01%	2333
2024 Q2	$35.6K	Hold	7,462	–	–	﹤0.01%	2832
2024 Q1	$50.7K	Hold	7,462	–	–	﹤0.01%	2684
2023 Q4	$36.5K	Hold	7,462	–	–	﹤0.01%	2821
2023 Q3	$25.5K	Hold	7,462	–	–	﹤0.01%	2762
2023 Q2	$35.7K	Hold	7,462	–	–	﹤0.01%	2687
2023 Q1	$31.5K	Hold	7,462	–	–	﹤0.01%	2751
2022 Q4	$28.8K	Hold	7,462	–	–	﹤0.01%	2808
2022 Q3	$45K	Hold	7,462	–	–	﹤0.01%	2602
2022 Q2	$26K	Hold	7,462	–	–	﹤0.01%	2906
2022 Q1	$26K	Hold	7,462	–	–	﹤0.01%	2926
2021 Q4	$22K	Hold	7,462	–	–	﹤0.01%	3058
2021 Q3	$30K	Hold	7,462	–	–	﹤0.01%	2907
2021 Q2	$38K	Hold	7,462	–	–	﹤0.01%	2796
2021 Q1	$35K	Hold	7,462	–	–	﹤0.01%	2756
2020 Q4	$26K	Hold	7,462	–	–	﹤0.01%	2783
2020 Q3	$39K	Hold	7,462	–	–	﹤0.01%	2515
2020 Q2	$34K	Hold	7,462	–	–	﹤0.01%	2578
2020 Q1	$9K	Hold	7,462	–	–	﹤0.01%	3051
2019 Q4	$10K	Hold	7,462	–	–	﹤0.01%	3094
2019 Q3	$28K	Hold	7,462	–	–	﹤0.01%	2702
2019 Q2	$25K	Sell	7,462 -1	-0%	-$4	﹤0.01%	2793
2019 Q1	$35K	Buy	+7,463	New	+$38.4K	﹤0.01%	2644

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

US Bancorp's CAPR Position: Q2 2026 in Review

US Bancorp reduced its Capricor Therapeutics (CAPR) stake by 1.4% in Q2 2026, selling an estimated $6K and leaving 14,235 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

US Bancorp first reported a position in CAPR in Q1 2019 and has held it in 30 quarters since. The position peaked at $439K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

US Bancorp held 14,235 shares of Capricor Therapeutics worth $343K as of Q2 2026.
US Bancorp sold 198 Capricor Therapeutics shares in Q2 2026, an estimated $6K.
Capricor Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1820 holding.
US Bancorp first reported a position in Capricor Therapeutics in Q1 2019 and has held it in 30 quarters since.
US Bancorp's Capricor Therapeutics position peaked at $439K in Q1 2026.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.